Juan Huertas v. Bayer US LLC, 120 F.4th 1169

Bayer recalled certain Lotrimin and Tinactin spray products in October 2021 after discovering benzene contamination in products manufactured from September 2018 to September 2021.
Plaintiffs (nine individuals) alleged economic harm from buying contaminated products, asserting those products were worth less or unusable, but did not allege physical injury.
The District Court dismissed the case, holding that plaintiffs failed to plausibly allege economic loss or injury-in-fact because their factual allegations were deemed insufficiently specific.
On appeal, the Third Circuit reviewed the benefit-of-the-bargain theory as the plaintiffs’ basis for economic injury, focusing on whether contaminated products are inherently worth less.
Only some plaintiffs provided lot numbers matching the recalled products; others failed to tie their purchases directly to the recall.
New evidence emerged post-dismissal, including a Bayer complaint against its supplier corroborating widespread contamination and product unfitness, which became relevant on appeal.

Issue	Plaintiff's Argument	Defendant's Argument	Held
Benefit-of-the-bargain economic injury	Plaintiffs did not get what they paid for; the products were unusable and thus worth less.	Products still worked as antifungals; mere contamination does not equal decreased product value without actual harm or nonperformance.	Contaminated, unusable products are plausibly worth less; plaintiffs can allege economic injury.
Sufficiency of factual allegations for standing	The recall, product testing (Valisure), and their product lot numbers show plausible benzene contamination in their purchases.	The recall and testing are not enough; no proof plaintiffs’ specific products were contaminated.	Plaintiffs who alleged relevant lot numbers and referenced evidence have plausibly alleged injury; others did not.
Impact of external litigation evidence (Aeropres Complaint)	Supports the inference that most recalled products, including plaintiffs’, were likely contaminated.	Bayer’s different stance in another lawsuit does not substitute for plaintiffs meeting pleading requirements.	District court should assess this evidence on remand but plaintiffs still must show standing in the amended complaint.
Standing for recall-period purchasers without lot number linkage	All purchases during recall period should be presumed contaminated.	Not all products during recall period were necessarily contaminated or recalled.	Dismissal upheld for plaintiffs without lot numbers tying their products to the recall.

In re Johnson & Johnson Talcum Powder Prod. Mktg., Sales Pracs. & Liab. Litig., 903 F.3d 278 (3d Cir. 2018) (benefit-of-the-bargain economic injury requires plausible allegations that the product received was worth less than bargained for)
Danvers Motor Co. v. Ford Motor Co., 432 F.3d 286 (3d Cir. 2005) (economic injury is a paradigmatic form of injury-in-fact under Article III)
Ashcroft v. Iqbal, 556 U.S. 662 (2009) (pleading standard for plausibility)
Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (requirements for plausible factual allegations)